secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2026-05-13T20:02:18+00:00
Accession:  0000718937-26-000022
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q1 net sales up 119.6% to $93.5M; returns to profitability with GAAP EPS $0.10
--------------------------------------------------------------------------------

- Record Q1 net sales of $93.5M, up 119.6% YoY, driven by China recovery and U.S. growth.
- GAAP net income $5.2M ($0.10 diluted EPS) vs net loss of $54.2M ($1.10 loss) a year ago.
- Adjusted EBITDA $24.4M ($0.48/share) vs adjusted EBITDA loss of $26.3M in prior year.
- Gross margin improved to 73.6% from 65.8%; operating expenses down 18% YoY.
- China distributor inventory normalized; EVO+ ICL launch early demand exceeded expectations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000071893726000022/0000718937-26-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000071893726000022/staa-20260512.htm
  HTML page:      https://secwatch.observer/filing/0000718937-26-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer